Detailed information for compound 981461

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 403.452 | Formula: C19H21N3O5S
  • H donors: 3 H acceptors: 5 LogP: 1.31 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1ccc2c1ncnc2SCc1ccc(cc1)OC
  • InChi: 1S/C19H21N3O5S/c1-26-12-4-2-11(3-5-12)9-28-18-13-6-7-22(17(13)20-10-21-18)19-16(25)15(24)14(8-23)27-19/h2-7,10,14-16,19,23-25H,8-9H2,1H3/t14-,15-,16-,19-/m1/s1
  • InChiKey: SETRXOQXMWXYMD-YKTARERQSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Toxoplasma gondii kinase, pfkB family protein Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Trypanosoma brucei gambiense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Echinococcus multilocularis adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Brugia malayi Adenosine kinase-like Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania major adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania donovani adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Onchocerca volvulus Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma mansoni adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania infantum adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Neospora caninum GG10762, related Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma cruzi adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Babesia bovis adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania braziliensis adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Cryptosporidium parvum adenosine kinase like ribokinase Get druggable targets OG5_128398 All targets in OG5_128398
Echinococcus granulosus adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Toxoplasma gondii kinase, pfkB family protein Get druggable targets OG5_128398 All targets in OG5_128398
Candida albicans putative adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma mansoni adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Candida albicans adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei gambiense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma cruzi adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma japonicum ko:K00856 adenosine kinase [EC2.7.1.20], putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma congolense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania mexicana adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni acetylcholinesterase 0.0287 0.1141 0.1141
Loa Loa (eye worm) hypothetical protein 0.0287 0.1141 0.1141
Schistosoma mansoni neuroligin 3 (S09 family) 0.0287 0.1141 0.1141
Onchocerca volvulus 0.0287 0.1141 0.5
Loa Loa (eye worm) hypothetical protein 0.1696 1 1
Mycobacterium tuberculosis Carboxylesterase LipT 0.0287 0.1141 0.5
Echinococcus multilocularis para nitrobenzyl esterase 0.0287 0.1141 0.1141
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0287 0.1141 0.1141
Trypanosoma brucei adenosine kinase, putative 0.0105 0 0.5
Trichomonas vaginalis carboxylesterase domain containing protein, putative 0.0287 0.1141 0.5
Loa Loa (eye worm) hypothetical protein 0.0287 0.1141 0.1141
Echinococcus multilocularis acetylcholinesterase 0.1696 1 1
Trypanosoma cruzi adenosine kinase, putative 0.0105 0 0.5
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0287 0.1141 0.5
Echinococcus granulosus BC026374 protein S09 family 0.0287 0.1141 0.1141
Loa Loa (eye worm) hypothetical protein 0.0287 0.1141 0.1141
Trypanosoma brucei adenosine kinase, putative 0.0105 0 0.5
Echinococcus multilocularis BC026374 protein (S09 family) 0.0287 0.1141 0.1141
Onchocerca volvulus 0.0287 0.1141 0.5
Echinococcus granulosus family S9 non peptidase ue S09 family 0.0287 0.1141 0.1141
Echinococcus multilocularis neuroligin 0.0287 0.1141 0.1141
Onchocerca volvulus 0.0287 0.1141 0.5
Echinococcus multilocularis family S9 non peptidase ue (S09 family) 0.0287 0.1141 0.1141
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.1696 1 1
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0287 0.1141 0.1141
Mycobacterium ulcerans carboxylesterase, LipT 0.0287 0.1141 0.5
Brugia malayi Carboxylesterase family protein 0.0287 0.1141 0.1141
Echinococcus multilocularis carboxylesterase 5A 0.1696 1 1
Onchocerca volvulus 0.0287 0.1141 0.5
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0287 0.1141 0.5
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0287 0.1141 0.1141
Brugia malayi hypothetical protein 0.0287 0.1141 0.1141
Leishmania major adenosine kinase, putative 0.0105 0 0.5
Onchocerca volvulus 0.0287 0.1141 0.5
Loa Loa (eye worm) acetylcholinesterase 1 0.1696 1 1
Loa Loa (eye worm) hypothetical protein 0.0287 0.1141 0.1141
Brugia malayi Carboxylesterase family protein 0.1696 1 1
Loa Loa (eye worm) carboxylesterase 0.1696 1 1
Loa Loa (eye worm) hypothetical protein 0.0287 0.1141 0.1141
Loa Loa (eye worm) hypothetical protein 0.1696 1 1
Echinococcus multilocularis acetylcholinesterase 0.1696 1 1
Echinococcus granulosus neuroligin 0.0287 0.1141 0.1141
Schistosoma mansoni BC026374 protein (S09 family) 0.0287 0.1141 0.1141
Brugia malayi Carboxylesterase family protein 0.0287 0.1141 0.1141
Toxoplasma gondii kinase, pfkB family protein 0.0105 0 0.5
Echinococcus granulosus carboxylesterase 5A 0.1696 1 1
Loa Loa (eye worm) carboxylesterase 0.0287 0.1141 0.1141
Trichomonas vaginalis spcc417.12 protein, putative 0.0287 0.1141 0.5
Loa Loa (eye worm) hypothetical protein 0.0287 0.1141 0.1141
Echinococcus granulosus acetylcholinesterase 0.1696 1 1
Schistosoma mansoni gliotactin 0.0287 0.1141 0.1141
Brugia malayi Carboxylesterase family protein 0.0287 0.1141 0.1141
Brugia malayi Carboxylesterase family protein 0.0287 0.1141 0.1141
Loa Loa (eye worm) carboxylesterase 0.0287 0.1141 0.1141
Echinococcus granulosus acetylcholinesterase 0.1696 1 1
Loa Loa (eye worm) hypothetical protein 0.0287 0.1141 0.1141
Trypanosoma cruzi adenosine kinase, putative 0.0105 0 0.5
Echinococcus granulosus para nitrobenzyl esterase 0.0287 0.1141 0.1141

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 4.6 uM Antitoxoplasma activity against wild type Toxoplasma gondii RH assessed as survival after 18 hrs by [5,6-13H]uracil incorporation assay ChEMBL. 18563892
Ki (binding) = 5.8 uM Binding affinity to purified Toxoplasma gondii adenosine kinase ChEMBL. 18563892
Survival (functional) = 0 % Antitoxoplasma activity against wild type Toxoplasma gondii RH assessed as survival at 25 uM after 18 hrs by [5,6-13H]uracil incorporation assay ChEMBL. 18563892
Survival (functional) = 0 % Antitoxoplasma activity against wild type Toxoplasma gondii RH assessed as survival at 50 uM after 18 hrs by [5,6-13H]uracil incorporation assay ChEMBL. 18563892
Survival (functional) = 5 % Antitoxoplasma activity against wild type Toxoplasma gondii RH assessed as survival at 10 uM after 18 hrs by [5,6-13H]uracil incorporation assay ChEMBL. 18563892
Survival (functional) = 49.8 % Antitoxoplasma activity against wild type Toxoplasma gondii RH assessed as survival at 5 uM after 18 hrs by [5,6-13H]uracil incorporation assay ChEMBL. 18563892
Survival (functional) = 100 % Antitoxoplasma activity against adenosine kinase deficient Toxoplasma gondii TgAK-3 assessed as survival at 5 uM after 18 hrs by [5,6-13H]uracil incorporation assay ChEMBL. 18563892
Survival (functional) = 100 % Antitoxoplasma activity against adenosine kinase deficient Toxoplasma gondii TgAK-3 assessed as survival at 10 uM after 18 hrs by [5,6-13H]uracil incorporation assay ChEMBL. 18563892
Survival (functional) = 100 % Antitoxoplasma activity against adenosine kinase deficient Toxoplasma gondii TgAK-3 assessed as survival at 25 uM after 18 hrs by [5,6-13H]uracil incorporation assay ChEMBL. 18563892
Survival (functional) = 100 % Antitoxoplasma activity against adenosine kinase deficient Toxoplasma gondii TgAK-3 assessed as survival at 50 uM after 18 hrs by [5,6-13H]uracil incorporation assay ChEMBL. 18563892

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Toxoplasma gondii ChEMBL23 18563892

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.